Evaluation of the NINCDS-ADRDA criteria in the differentiation of Alzheimer's disease and frontotemporal dementia
Varma AR, Snowden JS, Lloyd JJ et al. Evaluation of the NINCDS-ADRDA criteria in the differentiation of Alzheimer's disease and frontotemporal dementia. J Neurol Neurosurg Psychiatry 1999; 66: 184-8.
Larner AJ, Hancock P. The Utility of the Cambridge Behavioural Inventory in Neurodegenerative Disease. http://jnnp.bmj.com/cgi/eletters/79/5/500 (accessed 29 May 2008).
Diagnostic utility of the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) and its combination with the Addenbrooke's Cognitive Examination-Revised (ACE-R) in a memory clinic-based population
Hancock P, Larner AJ. Diagnostic utility of the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) and its combination with the Addenbrooke's Cognitive Examination-Revised (ACE-R) in a memory clinic-based population. Int Psychogeriatr 2009; 21: 526-30.
Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDAWork Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease
McKhann G, Drachman D, Folstein M et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDAWork Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984; 34: 939-44.
The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): socio-demographic correlates, reliability, validity and some norms
Jorm AF, Jacomb PA. The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): socio-demographic correlates, reliability, validity and some norms. Psychol Med 1989; 19: 1015-22.
Screening properties of the German IQCODE with a two-year time frame in MCI and early Alzheimer's disease
Ehrensperger MM, Berres M, Taylor KI et al. Screening properties of the German IQCODE with a two-year time frame in MCI and early Alzheimer's disease. Int Psychogeriatr 2010; 22: 91-100.